Achieve Announces Presentation of Investigator-Led RAUORA Trial Data Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix® (varenicline) in First Head-to-Head Comparative Study
Watch Achieve Life Sciences' latest callAchieve Life Sciences (NASDAQ:ACHV) Q1 2026 Earnings Call · Replay · May 12Read the transcript of Achieve Life Sciences (NASDAQ:ACHV) Q1 2026 Earnings CallAchieve Life Sciences, Inc. on 6ix
Story so far
- Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking
- Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
- Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
Earlier from Achieve Life Sciences
- Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program
- Achieve Life Sciences Announces Pricing of $6.5 Million Public Offering
- Achieve Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications
- Achieve Life Sciences to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020
- Achieve Life Sciences Announces Pricing of $6 Million Registered Direct Offering
Later from Achieve Life Sciences
- Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President
- Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
- Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020
- Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020
- Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
Follow Achieve Life Sciences into a list and get an email when it puts out news.
Follow Achieve Life Sciences